<h1 style="margin-bottom: 0.4em; text-align: center;">
    <b>Lecture 13B</b><br>
    Cheminformatics
</h1>
<h2 style="margin-top: 0.0em; text-align: center;">
    Methodology
</h2>
<p style="text-align: center;">
    <b>Date:</b> Apr 10, 2025
</p>

!!! danger "DRAFT"

    This page is a work in progress and is subject to change at any moment.

After today, you should have a better understanding of:

1.  The basic principles of ligand-based drug design and how it differs from structure-based approaches.
2.  How descriptors and fingerprints evaluate molecular similarity.
3.  How QSAR models predict biological activity based on molecular structure.
4.  The role of pharmacophore modeling in identifying essential molecular features for activity.

<!-- ## Presentation

-   **View:** [slides.com/aalexmmaldonado/biosc1540-l13b](https://slides.com/aalexmmaldonado/biosc1540-l13b)
-   **Live link:** [slides.com/d/9oH5ukw/live](https://slides.com/d/9oH5ukw/live)
-   **Download:** [biosc1540-l13b.pdf](/lectures/13B/biosc1540-l13b.pdf)

<iframe src="https://slides.com/aalexmmaldonado/biosc1540-l13b/embed?byline=hidden&share=hidden" width="100%" height="600" title="BIOSC 1540: Lecture 13B" scrolling="no" frameborder="0" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe> -->
